CADIAN CAPITAL MANAGEMENT, LP – Ultragenyx Pharmaceutical Inc. Transaction History
CADIAN CAPITAL MANAGEMENT, LP portfolio value:
$25.97M
portfolio value
CADIAN CAPITAL MANAGEMENT, LP quarter portfolio value change:
-30.59%
quarter
Ultragenyx Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -19.44% | -151.35K shares | -20.47M | $41.41 | 627.20K |
| Q2 2022 | share | Increase | 0.00% | 778.55K shares | 46.44M | $59.66 | 778.55K |